Alzheimer's disease
According to the company, its research into organoids and mouse models of Alzheimer's disease has resulted in the detection of roughly 800 proteoforms of the protein tau.
Esya Labs, Alamar Biosciences Partner on Biomarker Discovery Services
The companies will combine technologies to provide tailored assays for pharma firms developing therapies for neurological and inflammatory diseases.
Bio-Techne, Alzpath Partner on Neurodegenerative Disease Research
The companies have developed the Simple Plex Human Phospho-Tau (T217) Alzpath Assay using Bio-Techne's Ella immunoassay instrument.
Researchers from the federally funded sequencing project provided updates at the American Society of Human Genetics annual meeting.
Researchers used single-cell transcriptomics and proteomics to find cell type-specific features in post-mortem prefrontal cortex samples from Parkinson's disease patients.